{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T03:53:25Z","timestamp":1763783605121,"version":"3.45.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05288-4","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T03:48:31Z","timestamp":1763783311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual Mechanisms of Cognitive Function and Pathological Improvements by the Selective S1PR1\/5 Modulator Siponimod in 3xTg-AD Mice"],"prefix":"10.1007","volume":"63","author":[{"given":"Chao","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"20","key":"5288_CR1","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC (2023) Alzheimer\u2019s disease: from immunotherapy to immunoprevention. Cell 186(20):4260\u20134270. https:\/\/doi.org\/10.1016\/j.cell.2023.08.021","journal-title":"Cell"},{"issue":"3","key":"5288_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"issue":"7964","key":"5288_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T, Overhoff K, Steixner-Kumar AA et al (2023) Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature 618(7964):349\u2013357. https:\/\/doi.org\/10.1038\/s41586-023-06120-6","journal-title":"Nature"},{"issue":"1","key":"5288_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH (2023) Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. Inflammation 46(1):1\u201317. https:\/\/doi.org\/10.1007\/s10753-022-01721-1","journal-title":"Inflammation"},{"issue":"1","key":"5288_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9(1):42. https:\/\/doi.org\/10.1186\/s40035-020-00221-2","journal-title":"Transl Neurodegener"},{"issue":"9","key":"5288_CR6","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R (2021) Nlrp3 inflammasome activation and cell death. Cell Mol Immunol 18(9):2114\u20132127. https:\/\/doi.org\/10.1038\/s41423-021-00740-6","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"5288_CR7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s13760-020-01369-4","volume":"121","author":"R Yang","year":"2021","unstructured":"Yang R, Duan J, Luo F, Tao P, Hu C (2021) IL-6, IL-8 and IL-10 polymorphisms may impact predisposition of Alzheimer\u2019s disease: a meta-analysis. Acta Neurol Belg 121(6):1505\u20131512. https:\/\/doi.org\/10.1007\/s13760-020-01369-4","journal-title":"Acta Neurol Belg"},{"issue":"20","key":"5288_CR8","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","volume":"186","author":"N Sun","year":"2023","unstructured":"Sun N, Victor MB, Park YP, Xiong X, Scannail AN, Leary N, Prosper S, Viswanathan S et al (2023) Human microglial state dynamics in Alzheimer\u2019s disease progression. Cell 186(20):4386-4403.e29. https:\/\/doi.org\/10.1016\/j.cell.2023.08.037","journal-title":"Cell"},{"issue":"1","key":"5288_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01554-5","volume":"11","author":"M Maitre","year":"2023","unstructured":"Maitre M, Jeltsch-David H, Okechukwu NG, Klein C, Patte-Mensah C, Mensah-Nyagan AG (2023) Myelin in Alzheimer\u2019s disease: culprit or bystander? Acta Neuropathol Commun 11(1):56. https:\/\/doi.org\/10.1186\/s40478-023-01554-5","journal-title":"Acta Neuropathol Commun"},{"issue":"14","key":"5288_CR10","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.neuron.2021.05.012","volume":"109","author":"JF Chen","year":"2021","unstructured":"Chen JF, Liu K, Hu B, Li RR, Xin W, Chen H, Wang F, Chen L et al (2021) Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer\u2019s disease. Neuron 109(14):2292-2307.e5. https:\/\/doi.org\/10.1016\/j.neuron.2021.05.012","journal-title":"Neuron"},{"key":"5288_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb8680","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K, Chan ER, Wang Q et al (2020) Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer\u2019s disease. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abb8680","journal-title":"Sci Adv"},{"key":"5288_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2022.148171","volume":"1799","author":"Y Jung","year":"2023","unstructured":"Jung Y, Lopez-Benitez J, Tognoni CM, Carreras I, Dedeoglu A (2023) Dysregulation of sphingosine-1-phosphate (S1P) and S1P receptor 1 signaling in the 5xFAD mouse model of Alzheimer\u2019s disease. Brain Res 1799:148171. https:\/\/doi.org\/10.1016\/j.brainres.2022.148171","journal-title":"Brain Res"},{"key":"5288_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biom13020331","author":"P Bascu\u00f1ana","year":"2023","unstructured":"Bascu\u00f1ana P, Brackhan M, M\u00f6hle L, Wu J, Br\u00fcning T, Eiriz I, Jansone B, Pahnke J (2023) Time- and sex-dependent effects of fingolimod treatment in a mouse model of Alzheimer\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom13020331","journal-title":"Biomolecules"},{"key":"5288_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132058","author":"G Bravo","year":"2022","unstructured":"Bravo G, Cede\u00f1o RR, Casadevall MP, Rami\u00f3-Torrent\u00e0 L (2022) Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives. Cells. https:\/\/doi.org\/10.3390\/cells11132058","journal-title":"Cells"},{"key":"5288_CR15","doi-asserted-by":"publisher","unstructured":"Wunsch F, Nguyen TN, Wolber G, Bermudez M (2023) Structural determinants of sphingosine-1-phosphate receptor selectivity. Archiv der Pharmazie 356(12):e2300387.\u00a0https:\/\/doi.org\/10.1002\/ardp.202300387","DOI":"10.1002\/ardp.202300387"},{"key":"5288_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.648636","volume":"12","author":"HZ Long","year":"2021","unstructured":"Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC (2021) PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease. Front Pharmacol 12:648636. https:\/\/doi.org\/10.3389\/fphar.2021.648636","journal-title":"Front Pharmacol"},{"key":"5288_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainresbull.2020.08.013","volume":"164","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang H (2020) FTY720 in CNS injuries: molecular mechanisms and therapeutic potential. Brain Res Bull 164:75\u201382. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.08.013","journal-title":"Brain Res Bull"},{"issue":"1","key":"5288_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12035-021-02611-7","volume":"59","author":"M Kumar","year":"2022","unstructured":"Kumar M, Bansal N (2022) Implications of phosphoinositide 3-kinase-Akt (PI3K-Akt) pathway in the pathogenesis of Alzheimer\u2019s disease. Mol Neurobiol 59(1):354\u2013385. https:\/\/doi.org\/10.1007\/s12035-021-02611-7","journal-title":"Mol Neurobiol"},{"issue":"7\u20138","key":"5288_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10495-023-01848-y","volume":"28","author":"S Kumari","year":"2023","unstructured":"Kumari S, Dhapola R, Reddy DH (2023) Apoptosis in Alzheimer\u2019s disease: insight into the signaling pathways and therapeutic avenues. Apoptosis 28(7\u20138):943\u2013957. https:\/\/doi.org\/10.1007\/s10495-023-01848-y","journal-title":"Apoptosis"},{"key":"5288_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061515","author":"A Lucaciu","year":"2020","unstructured":"Lucaciu A, Brunkhorst R, Pfeilschifter JM, Pfeilschifter W, Subburayalu J (2020) The S1P\u2013S1PR axis in neurological disorders-insights into current and future therapeutic perspectives. Cells. https:\/\/doi.org\/10.3390\/cells9061515","journal-title":"Cells"},{"issue":"2","key":"5288_CR21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301557RR","volume":"38","author":"E Willems","year":"2024","unstructured":"Willems E, Schepers M, Piccart E, Wolfs E, Hellings N, Ait-Tihyaty M, Vanmierlo T (2024) The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation. FASEB J 38(2):e23413. https:\/\/doi.org\/10.1096\/fj.202301557RR","journal-title":"FASEB J"},{"key":"5288_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001161","author":"M Dietrich","year":"2022","unstructured":"Dietrich M, Hecker C, Martin E, Langui D, Gliem M, Stankoff B, Lubetzki C, Gruchot J et al (2022) Increased remyelination and proregenerative microglia under siponimod therapy in mechanistic models. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/nxi.0000000000001161","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"5288_CR23","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00204-018-2189-9","volume":"92","author":"F Pognan","year":"2018","unstructured":"Pognan F, Mahl JA, Papoutsi M, Ledieu D, Raccuglia M, Theil D, Voytek SB, Devine PJ et al (2018) Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and human. Arch Toxicol 92(5):1877\u20131891. https:\/\/doi.org\/10.1007\/s00204-018-2189-9","journal-title":"Arch Toxicol"},{"issue":"3","key":"5288_CR24","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s12035-021-02613-5","volume":"59","author":"SG Fagan","year":"2022","unstructured":"Fagan SG, Bechet S, Dev KK (2022) Fingolimod rescues memory and improves pathological hallmarks in the 3xTg-AD model of Alzheimer\u2019s disease. Mol Neurobiol 59(3):1882\u20131895. https:\/\/doi.org\/10.1007\/s12035-021-02613-5","journal-title":"Mol Neurobiol"},{"key":"5288_CR25","doi-asserted-by":"publisher","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z (2019) The open field test for measuring locomotor activity and anxiety-like behavior. Methods Mol Biol (Clifton, NJ) 1916:99\u2013103.\u00a0https:\/\/doi.org\/10.1007\/978-1-4939-8994-2_9","DOI":"10.1007\/978-1-4939-8994-2_9"},{"key":"5288_CR26","doi-asserted-by":"publisher","unstructured":"Lueptow LM (2017) Novel object recognition test for the investigation of learning and memory in mice. Journal of visualized experiments : JoVE 30;(126).\u00a0https:\/\/doi.org\/10.3791\/55718","DOI":"10.3791\/55718"},{"key":"5288_CR27","doi-asserted-by":"publisher","unstructured":"Bromley-Brits K, Deng Y, Song W (2011) Morris water maze test for learning and memory deficits in Alzheimer\u2019s disease model mice. Journal of visualized experiments : JoVE 20;(53).\u00a0https:\/\/doi.org\/10.3791\/2920","DOI":"10.3791\/2920"},{"issue":"3","key":"5288_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","volume":"30","author":"SH Baik","year":"2019","unstructured":"Baik SH, Kang S, Lee W, Choi H, Chung S, Kim JI, Mook-Jung I (2019) A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer\u2019s disease. Cell Metab 30(3):493-507.e6. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.005","journal-title":"Cell Metab"},{"issue":"9","key":"5288_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1590\/0004-282x20170110","volume":"75","author":"CA Magalh\u00e3es","year":"2017","unstructured":"Magalh\u00e3es CA, Carvalho MDG, Sousa LP, Caramelli P, Gomes KB (2017) Alzheimer\u2019s disease and cytokine IL-10 gene polymorphisms: is there an association? Arq Neuropsiquiatr 75(9):649\u2013656. https:\/\/doi.org\/10.1590\/0004-282x20170110","journal-title":"Arq Neuropsiquiatr"},{"key":"5288_CR30","doi-asserted-by":"publisher","unstructured":"Lopez-Rodriguez AB, Hennessy E, Murray CL, Nazmi A, Delaney HJ, Healy D, Fagan SG, Rooney M et al (2021) Acute systemic inflammation exacerbates neuroinflammation in Alzheimer\u2019s disease: IL-1\u03b2 drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimers & Dement 17(10):1735\u20131755.\u00a0https:\/\/doi.org\/10.1002\/alz.12341","DOI":"10.1002\/alz.12341"},{"issue":"1","key":"5288_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/alz.13490","volume":"20","author":"S Gaikwad","year":"2024","unstructured":"Gaikwad S, Senapati S, Haque MA, Kayed R (2024) Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer\u2019s disease: evidence from clinical and preclinical studies. Alzheimers Dement 20(1):709\u2013727. https:\/\/doi.org\/10.1002\/alz.13490","journal-title":"Alzheimers Dement"},{"key":"5288_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101464","volume":"72","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yang X, Song YQ, Tu J (2021) Autophagy in Alzheimer\u2019s disease pathogenesis: therapeutic potential and future perspectives. Ageing Res Rev 72:101464. https:\/\/doi.org\/10.1016\/j.arr.2021.101464","journal-title":"Ageing Res Rev"},{"issue":"9","key":"5288_CR33","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.tins.2021.06.007","volume":"44","author":"A Guerrero","year":"2021","unstructured":"Guerrero A, De Strooper B, Arancibia-C\u00e1rcamo IL (2021) Cellular senescence at the crossroads of inflammation and Alzheimer\u2019s disease. Trends Neurosci 44(9):714\u2013727. https:\/\/doi.org\/10.1016\/j.tins.2021.06.007","journal-title":"Trends Neurosci"},{"key":"5288_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells11071237","author":"L Scipioni","year":"2022","unstructured":"Scipioni L, Ciaramellano F, Carnicelli V, Leuti A, Lizzi AR, De Dominicis N, Oddi S, Maccarrone M (2022) Microglial endocannabinoid signalling in AD. Cells. https:\/\/doi.org\/10.3390\/cells11071237","journal-title":"Cells"},{"key":"5288_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe3600","author":"J Cheng","year":"2021","unstructured":"Cheng J, Dong Y, Ma J, Pan R, Liao Y, Kong X, Li X, Li S et al (2021) Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer\u2019s disease pathology. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abe3600","journal-title":"Sci Adv"},{"key":"5288_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H (2022) Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets. Front Immunol 13:856376. https:\/\/doi.org\/10.3389\/fimmu.2022.856376","journal-title":"Front Immunol"},{"key":"5288_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101622","volume":"78","author":"MS Uddin","year":"2022","unstructured":"Uddin MS, Lim LW (2022) Glial cells in Alzheimer\u2019s disease: from neuropathological changes to therapeutic implications. Ageing Res Rev 78:101622. https:\/\/doi.org\/10.1016\/j.arr.2022.101622","journal-title":"Ageing Res Rev"},{"issue":"12","key":"5288_CR38","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1038\/s41593-023-01524-z","volume":"26","author":"R Wright","year":"2023","unstructured":"Wright R (2023) Myelin and Alzheimer\u2019s disease. Nat Neurosci 26(12):2048. https:\/\/doi.org\/10.1038\/s41593-023-01524-z","journal-title":"Nat Neurosci"},{"issue":"7","key":"5288_CR39","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","volume":"109","author":"S Safaiyan","year":"2021","unstructured":"Safaiyan S, Besson-Girard S, Kaya T, Cantuti-Castelvetri L, Liu L, Ji H, Schifferer M, Gouna G et al (2021) White matter aging drives microglial diversity. Neuron 109(7):1100-1117.e10. https:\/\/doi.org\/10.1016\/j.neuron.2021.01.027","journal-title":"Neuron"},{"issue":"8","key":"5288_CR40","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s11064-024-04173-1","volume":"49","author":"L Pouzol","year":"2024","unstructured":"Pouzol L, Sassi A, Tunis M, Zurbach A, Baumlin N, Gnerre C, Strasser DS, Marrie J et al (2024) Ackr3 antagonism enhances the repair of demyelinated lesions through both immunomodulatory and remyelinating effects. Neurochem Res 49(8):2087\u20132104. https:\/\/doi.org\/10.1007\/s11064-024-04173-1","journal-title":"Neurochem Res"},{"issue":"11","key":"5288_CR41","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1177\/1352458517721355","volume":"24","author":"A Mannioui","year":"2018","unstructured":"Mannioui A, Vauzanges Q, Fini JB, Henriet E, Sekizar S, Azoyan L, Thomas JL, Pasquier DD et al (2018) The Xenopus tadpole: an in vivo model to screen drugs favoring remyelination. Mult Scler J 24(11):1421\u20131432. https:\/\/doi.org\/10.1177\/1352458517721355","journal-title":"Mult Scler J"},{"issue":"1","key":"5288_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68715-x","volume":"14","author":"HH Hendek","year":"2024","unstructured":"Hendek HH, Blusch A, Heitmann N, Oberhagemann S, Demir S, Pedreiturria X, Gold R, Faissner S (2024) Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models. Sci Rep 14(1):17823. https:\/\/doi.org\/10.1038\/s41598-024-68715-x","journal-title":"Sci Rep"},{"issue":"1","key":"5288_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87825-8","volume":"15","author":"J Kr\u00fcger","year":"2025","unstructured":"Kr\u00fcger J, Behrangi N, Schliep D, Heinig L, Vankriekelsvenne E, Wigger N, Kipp M (2025) Siponimod supports remyelination in the non-supportive environment. Sci Rep 15(1):4216. https:\/\/doi.org\/10.1038\/s41598-025-87825-8","journal-title":"Sci Rep"},{"key":"5288_CR44","doi-asserted-by":"publisher","unstructured":"Al-Otaibi KM, Alghamdi BS, Al-Ghamdi MA, Mansouri RA, Ashraf GM, Omar UM (2022) Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis. Front Behav Neurosci 16:1068736.\u00a0https:\/\/doi.org\/10.3389\/fnbeh.2022.1068736","DOI":"10.3389\/fnbeh.2022.1068736"},{"issue":"6","key":"5288_CR45","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/brain\/awad051","volume":"146","author":"E Henriet","year":"2023","unstructured":"Henriet E, Martin EM, Jubin P, Langui D, Mannioui A, Stankoff B, Lubetzki C, Khakhalin A et al (2023) Monitoring recovery after CNS demyelination, a novel tool to de-risk pro-remyelinating strategies. Brain 146(6):2453\u20132463. https:\/\/doi.org\/10.1093\/brain\/awad051","journal-title":"Brain"},{"key":"5288_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043716","author":"M Enders","year":"2023","unstructured":"Enders M, Weier A, Chunder R, An Y, Bremm F, Feigenspan A, Buettner C, Ekici AB et al (2023) Impact of the voltage-gated calcium channel antagonist nimodipine on the development of oligodendrocyte precursor cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24043716","journal-title":"Int J Mol Sci"},{"key":"5288_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1516991","volume":"16","author":"S Chen","year":"2025","unstructured":"Chen S, Wu L, Lang B, Zhao G, Zhang W (2025) Sphingosine 1-phosphate receptor 1 modulators exert neuroprotective effects in central nervous system disorders. Front Pharmacol 16:1516991. https:\/\/doi.org\/10.3389\/fphar.2025.1516991","journal-title":"Front Pharmacol"},{"issue":"28","key":"5288_CR48","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2174\/0115680266288509240422112839","volume":"24","author":"SS Kar","year":"2024","unstructured":"Kar SS, Gharai SR, Sahu SK, Ravichandiran V, Swain SP (2024) The current landscape in the development of small-molecule modulators targeting sphingosine-1-phosphate receptors to treat neurodegenerative diseases. Curr Top Med Chem 24(28):2431\u20132446. https:\/\/doi.org\/10.2174\/0115680266288509240422112839","journal-title":"Curr Top Med Chem"},{"key":"5288_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114264","volume":"278","author":"M Zheng","year":"2021","unstructured":"Zheng M, Liu Z, Mana L, Qin G, Huang S, Gong Z, Tian M, He Y et al (2021) Shenzhiling oral liquid protects the myelin sheath against Alzheimer\u2019s disease through the PI3K\/Akt-mTOR pathway. J Ethnopharmacol 278:114264. https:\/\/doi.org\/10.1016\/j.jep.2021.114264","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"5288_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-021-02900-x","volume":"11","author":"G Qin","year":"2021","unstructured":"Qin G, Wang Y, Liu Z, Mana L, Huang S, Wang P (2021) Shenzhiling oral solution promotes myelin repair through PI3K\/Akt-mTOR pathway in STZ-induced SAD mice. 3 Biotech 11(7):361. https:\/\/doi.org\/10.1007\/s13205-021-02900-x","journal-title":"3 Biotech"},{"key":"5288_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102354","volume":"54","author":"H Cao","year":"2022","unstructured":"Cao H, Zuo C, Gu Z, Huang Y, Yang Y, Zhu L, Jiang Y, Wang F (2022) High frequency repetitive transcranial magnetic stimulation alleviates cognitive deficits in 3xTg-AD mice by modulating the PI3K\/Akt\/GLT-1 axis. Redox Biol 54:102354. https:\/\/doi.org\/10.1016\/j.redox.2022.102354","journal-title":"Redox Biol"},{"issue":"1","key":"5288_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep24939","volume":"6","author":"N Aytan","year":"2016","unstructured":"Aytan N, Choi JK, Carreras I, Brinkmann V, Kowall NW, Jenkins BG, Dedeoglu A (2016) Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer\u2019s disease. Sci Rep 6(1):24939. https:\/\/doi.org\/10.1038\/srep24939","journal-title":"Sci Rep"},{"issue":"16","key":"5288_CR53","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.2174\/1389450116666151001112710","volume":"17","author":"LM Healy","year":"2016","unstructured":"Healy LM, Antel JP (2016) Sphingosine-1-phosphate receptors in the central nervous and immune systems. Curr Drug Targets 17(16):1841\u20131850. https:\/\/doi.org\/10.2174\/1389450116666151001112710","journal-title":"Curr Drug Targets"},{"issue":"3","key":"5288_CR54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z, Huang R, Wang D et al (2017) Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med 214(3):597\u2013607. https:\/\/doi.org\/10.1084\/jem.20160844","journal-title":"J Exp Med"},{"issue":"1","key":"5288_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4527283","volume":"2020","author":"Z Liu","year":"2020","unstructured":"Liu Z, Qin G, Mana L, Huang S, Wang Y, Wang P (2020) Shenzhiling oral liquid protects STZ-injured oligodendrocyte through PI3K\/Akt-mTOR pathway. Evid Based Complement Alternat Med 2020(1):4527283. https:\/\/doi.org\/10.1155\/2020\/4527283","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"5288_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lfs.2017.05.010","volume":"180","author":"SQ Liu","year":"2017","unstructured":"Liu SQ, Zhang ML, Zhang HJ, Liu FZ, Chu RJ, Zhang GX, Zhu L (2017) Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K\/Akt signaling pathway. Life Sci 180:36\u201341. https:\/\/doi.org\/10.1016\/j.lfs.2017.05.010","journal-title":"Life Sci"},{"key":"5288_CR57","doi-asserted-by":"publisher","DOI":"10.1177\/2058738420923907","volume":"34","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chen F, Wang P, Mana L, Sheng N, Huang S (2020) Study on myelin injury of AD mice treated with Shenzhiling oral liquid in the PI3K\/Akt-mTOR pathway. Int J Immunopathol Pharmacol 34:2058738420923907. https:\/\/doi.org\/10.1177\/2058738420923907","journal-title":"Int J Immunopathol Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05288-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05288-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05288-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T03:48:32Z","timestamp":1763783312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05288-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5288"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05288-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"133"}}